Document Detail

Serum levels of VEGF and VEGF-C in patients with endometrial cancer.
MedLine Citation:
PMID:  21411409     Owner:  NLM     Status:  MEDLINE    
Endometrial cancer (EC) is the most common type of uterine cancer. A dualistic model of endometrial tumorigenesis serves as a useful way of categorizing these cancers in terms of both etiology and clinical behavior. There are two types of EC: type I and type II. Type I is so-called estrogen-dependent, and appears mostly in pre- and perimenopausal women, it is well differentiated and therefore has a better prognosis. Type II EC is estrogen-independent, diagnosed mostly in postmenopausal women, thin and fertile women, or in women with normal menstrual cycles. It is aggressive and has a worse prognosis than type I. The aim of this study was to evaluate the relationship between the pretreatment serum levels of VEGF and VEGF-C and the outcome of EC patients. A total of 98 patients treated between 1999 and 2003 were included in this study. Circulating VEGF and VEGF-C levels were determined using ELISA kits. VEGF levels among the 76 patients with type I, and the 22 patients with type II EC were significantly higher than those found in the healthy control subjects (p < 0.001). The differences in mean values of VEGF-C were highly significant in both types of tumor examined compared to the control (p < 0.001). The results demonstrate that serum VEGF concentration correlated significantly with advanced FIGO stage in type II EC (p < 0.001). The preoperative VEGF-C level correlated with advancing tumor stages in type I EC (p < 0.05). An elevated preoperative VEGF-C was an independent risk factor for disease-specific survival in patients with type II tumors. Thus, in type II EC patients with high preoperative levels of VEGF-C, pelvic and para-aortic lymphadenectomy should be performed. However, the value of longitudinal measurements of the markers used is yet to be determined.
Bozena Dobrzycka; Slawomir J Terlikowski; Oksana Kowalczuk; Marek Kulikowski; Jacek Niklinski
Related Documents :
21360029 - Correlates of colorectal cancer screening adherence among men who have been screened fo...
24829659 - Mucin profile expression in gastric adenocarcinoma.
23540689 - Interplay between the cancer genome and epigenome.
23479369 - Smoking and colorectal cancer risk by tumor genetic and epigenetic subtypes: a molecula...
23108289 - Research and clinical applications of cancer genome sequencing.
19616149 - An overview of the cancer burden for primary care physicians.
24349579 - Correction: improvement of a predictive model of castration-resistant prostate cancer: ...
17369669 - Ill patient, public activist: rose kushner's attack on breast cancer chemotherapy.
14607639 - Surgical approaches for resection of pancreatic cancer: an overview.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European cytokine network     Volume:  22     ISSN:  1952-4005     ISO Abbreviation:  Eur. Cytokine Netw.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-04-04     Completed Date:  2011-07-26     Revised Date:  2012-08-31    
Medline Journal Info:
Nlm Unique ID:  9100879     Medline TA:  Eur Cytokine Netw     Country:  France    
Other Details:
Languages:  eng     Pagination:  45-51     Citation Subset:  IM    
Department of Obstetrics, Gynecology and Obstetrics/Gynecological Care, Medical University of Bialystok, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Endometrial Neoplasms / blood*,  surgery
Kaplan-Meier Estimate
Middle Aged
Neoplasm Staging
Preoperative Care
Vascular Endothelial Growth Factor A / blood*
Vascular Endothelial Growth Factor C / blood*
Reg. No./Substance:
0/VEGFA protein, human; 0/VEGFC protein, human; 0/Vascular Endothelial Growth Factor A; 0/Vascular Endothelial Growth Factor C

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Rate Control Scheme for Consistent Video Quality in Scalable Video Codec.
Next Document:  Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrom...